2 Under-the-Radar Dividend Kings to Buy in Bunches

Northwest Natural hit a 52-week high of $53.66 on March 30, reported 2025 EPS of $2.77 (+36.4%) and provided 2026 EPS guidance of $2.95–$3.15 (midpoint +10.1%); growth driven by acquisitions (SiEnergy for $427M adding >90,000 customers) and a Washington rate settlement allowing $20.1M in revenue this year. Marzetti (formerly Lancaster Colony) is debt-free, yielding ~2.9% with a 5% dividend increase in 2025 and 63 consecutive years of raises, reported Q2 FY26 revenue of $1.01B (+3.6%) and EPS $3.86 (+13.5%), and spent $400M to acquire Bachan's; shares are down ~14% YTD. Both mid-cap Dividend Kings show stable cash flows, dividend resilience and inorganic growth, making them attractive for income-oriented portfolios.

Analysis

Northwest Natural’s playbook—buying regulated water and out-of-region gas footprints—creates a portfolio of differently paced, regulatory-protected cashflows. That mix can mechanically smooth volatility in earnings but also creates a mismatch in capital intensity and allowed returns: water/wastewater projects tend to have longer-lived assets and different rate-case mechanics than gas distribution, so consolidation benefits will show up more in regulated asset growth and steadier FCF rather than margin expansion. The company’s acquisition cadence turns corporate capital allocation into the primary operational lever — success is now more about win-rate on rate cases, integration capex control, and marginal ROE on acquired rate bases than about commodity exposure.

Marzetti’s capital structure flexibility is a strategic advantage for buying niche brands, but its economics hinge on distribution and restaurant-license concentration. Licensing deals can deliver high incremental margins but are lumpy and contract-sensitive; a single large partner re-negotiation would compress near-term EBITDA more than an equivalent drop in retail SKU volume. Recent M&A suggests management prefers bolt-ons for steady organic-like growth, which tightens the timeline for realizing cost synergies and justifies active monitoring of acquisition multiples and SKU rationalization outcomes.

Near-term catalysts to watch are state-level rate decisions, quarterly guidance vs. freshly consolidated revenues from recent buys, and any update on water capex plans — these move headlines and re-rate multiples within days-weeks. Medium-term risks (12–36 months) include adverse regulatory outcomes, faster-than-expected residential electrification reducing gas throughput, or restaurant licensing churn that depresses branded sauce volumes; any of these could erase a year of acquisition-driven upside. The market appears to underprice regulatory optionality embedded in utility-style water assets while underestimating concentration risk in branded food licensing, creating asymmetric opportunities for selective, paired trades.

Key Decisions for Investors

• Long NWN vs short large regulated peer (NWN long / D short) — size the pair 1:1, 12–18 month horizon. Entry: initiate after an 8–12% NWN pullback or within 5 trading days of a neutral-to-accretive rate-case ruling. Target: 18–25% absolute upside on NWN with expected relative outperformance of 8–12%; risk: regulatory reversal or integration cost overruns could produce a 20% downside. Use a 20% stop on the NWN leg and trim at 12–15% realized gain.
• Directional option: NWN Jan 2028 LEAP call spread (buy Jan-2028 LEAP call, sell a higher strike call to fund 40–60% of premium) — 18–36 month asymmetric upside if acquisitions re-rate. Benefit: limited premium with multi-year optionality. Risk: time decay and a multi-quarter miss on rate-case-driven cashflows.
• Buy MZTI shares on a 6–10% dip; target 12-month total return of 20–30% driven by tuck-in accretion and margin improvement. Size as a tactical core food-staples holding with a 12% position-level stop-loss. Monitor: any loss of a major license partner or material commodity-cost surprise as triggers to re-assess.
• Income entry for MZTI: sell cash-secured, 10% OTM puts with ~12-month tenor to harvest yield and acquire at a discount. Rationale: management has shown acquisition appetite and balance-sheet optionality; downside is owning the stock at a lower basis. Limit allocation to 2–4% of portfolio per put to control assignment risk.